Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125573912 | 12557391 | 2 | F | 20150709 | 20160831 | 20160714 | 20160913 | EXP | JP-CELGENEUS-JPN-2015090456 | CELGENE | 73.94 | YR | M | Y | 0.00000 | 20160913 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125573912 | 12557391 | 1 | PS | POMALYST | POMALIDOMIDE | 1 | Oral | U | 204026 | 2 | MG | CAPSULES | QD | ||||||
125573912 | 12557391 | 2 | SS | POMALYST | POMALIDOMIDE | 1 | Oral | U | 204026 | 4 | MG | CAPSULES | QD | ||||||
125573912 | 12557391 | 3 | SS | POMALYST | POMALIDOMIDE | 1 | Oral | U | 204026 | 3 | MG | CAPSULES | QD | ||||||
125573912 | 12557391 | 4 | SS | LENADEX | DEXAMETHASONE ACETATE | 1 | Oral | 300 MILLIGRAM | U | 0 | 20 | MG | TABLETS | /wk | |||||
125573912 | 12557391 | 5 | SS | LENADEX | DEXAMETHASONE ACETATE | 1 | Oral | 1500 MILLIGRAM | U | 0 | 20 | MG | TABLETS | /wk | |||||
125573912 | 12557391 | 6 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | 21880 | CAPSULES | ||||||||
125573912 | 12557391 | 7 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 10 MILLIGRAM | U | U | 0 | 20 | MG | TABLETS | QD | ||||
125573912 | 12557391 | 8 | C | Cibenzoline Succinate | CIFENLINE SUCCINATE | 1 | Oral | 600 MILLIGRAM | 0 | 100 | MG | TABLETS | TID | ||||||
125573912 | 12557391 | 9 | C | Maglax | MAGNESIUM OXIDE | 1 | Oral | 12 MILLIGRAM | 0 | 500 | MG | TABLETS | TID | ||||||
125573912 | 12557391 | 10 | C | Pantosin | PANTETHINE | 1 | Oral | 20 MILLIGRAM | 0 | 200 | MG | TABLETS | TID | ||||||
125573912 | 12557391 | 11 | C | Sennoside | SENNOSIDES | 1 | Oral | 15 MILLIGRAM | 0 | 12 | MG | TABLETS | QD | ||||||
125573912 | 12557391 | 12 | C | Famotidine D | FAMOTIDINE | 1 | Oral | 100 MILLIGRAM | 0 | 20 | MG | TABLETS | QD | ||||||
125573912 | 12557391 | 13 | C | Sigmart | NICORANDIL | 1 | Oral | 40 MILLIGRAM | 0 | 5 | MG | TABLETS | TID | ||||||
125573912 | 12557391 | 14 | C | HERBESSER | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 1 DOSAGE FORMS | 0 | 100 | MG | CAPSULES | QD | ||||||
125573912 | 12557391 | 15 | C | Frandol S | ISOSORBIDE DINITRATE | 1 | Transdermal | 200 MILLIGRAM | 0 | 40 | MG | POULTICE OR PATCH | QD | ||||||
125573912 | 12557391 | 16 | C | Baktar | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 0 | 1 | DF | TABLETS | QD | |||||||
125573912 | 12557391 | 17 | C | ZOVIRAX | ACYCLOVIR | 1 | Oral | 0 | 200 | MG | GRANULATE | QD | |||||||
125573912 | 12557391 | 18 | C | Negmin | 2 | Oropharingeal | 400 MILLIGRAM | 0 | GARGLE | QD | |||||||||
125573912 | 12557391 | 19 | C | Resutamin Kowa | 2 | Transdermal | 20 MILLIGRAM | 0 | CREAM | BID | |||||||||
125573912 | 12557391 | 20 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | 40 MILLIGRAM | 0 | 200 | MG | TABLETS | BID | ||||||
125573912 | 12557391 | 21 | C | Glimicron | GLICLAZIDE | 1 | Oral | 0 | 20 | MG | TABLETS | BID | |||||||
125573912 | 12557391 | 22 | C | Feburic | FEBUXOSTAT | 1 | Oral | 0 | 10 | MG | TABLETS | QD | |||||||
125573912 | 12557391 | 23 | C | G-Lasta | PEGFILGRASTIM | 1 | Subcutaneous | 0 | INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125573912 | 12557391 | 1 | Plasma cell myeloma |
125573912 | 12557391 | 4 | Plasma cell myeloma |
125573912 | 12557391 | 6 | Plasma cell myeloma |
125573912 | 12557391 | 7 | Product used for unknown indication |
125573912 | 12557391 | 8 | Product used for unknown indication |
125573912 | 12557391 | 9 | Product used for unknown indication |
125573912 | 12557391 | 10 | Product used for unknown indication |
125573912 | 12557391 | 11 | Product used for unknown indication |
125573912 | 12557391 | 12 | Prophylaxis |
125573912 | 12557391 | 13 | Product used for unknown indication |
125573912 | 12557391 | 14 | Product used for unknown indication |
125573912 | 12557391 | 15 | Product used for unknown indication |
125573912 | 12557391 | 16 | Prophylaxis |
125573912 | 12557391 | 17 | Prophylaxis |
125573912 | 12557391 | 18 | Prophylaxis |
125573912 | 12557391 | 19 | Product used for unknown indication |
125573912 | 12557391 | 20 | Plasma cell myeloma |
125573912 | 12557391 | 21 | Product used for unknown indication |
125573912 | 12557391 | 22 | Product used for unknown indication |
125573912 | 12557391 | 23 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125573912 | 12557391 | HO |
125573912 | 12557391 | OT |
125573912 | 12557391 | DE |
125573912 | 12557391 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125573912 | 12557391 | Acute kidney injury | |
125573912 | 12557391 | Cerebral infarction | |
125573912 | 12557391 | Dehydration | |
125573912 | 12557391 | Haemoglobin decreased | |
125573912 | 12557391 | Hypoglycaemia | |
125573912 | 12557391 | Lymphocyte count decreased | |
125573912 | 12557391 | Neutrophil count decreased | |
125573912 | 12557391 | Platelet count decreased | |
125573912 | 12557391 | Upper gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125573912 | 12557391 | 1 | 20150703 | 20150716 | 0 | |
125573912 | 12557391 | 2 | 20150717 | 20150723 | 0 | |
125573912 | 12557391 | 3 | 20150810 | 20150818 | 0 | |
125573912 | 12557391 | 4 | 20150703 | 20150723 | 0 | |
125573912 | 12557391 | 5 | 20150810 | 20150817 | 0 | |
125573912 | 12557391 | 6 | 20150414 | 20150504 | 0 |